Ordinary Rebalance | Solactive China Biotech Indices | Effective Date 16th January 2023
Solactive China Biotech Index:
In the ordinary rebalance, the following index composition will be implemented effective open 16.01.2023:
| AKESO INC | 2.8181 % |
| APELOA PHARMACEUTICAL CO-A | 1.9768 % |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD | 0.7253 % |
| BETTA PHARMACEUTICALS CO L-A | 2.4804 % |
| BGI GENOMICS CO LTD-A | 1.5952 % |
| CANSINO BIOLOGICS INC | 0.3852 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.1369 % |
| DAAN GENE CO LTD-A | 2.2629 % |
| GENSCRIPT BIOTECH CORP | 3.1302 % |
| HANSOH PHARMACEUTICAL GROUP CO | 2.2473 % |
| HUALAN BIOLOGICAL ENGINEER-A | 3.4914 % |
| HUBEI JUMPCAN PHARMACEUT-A | 1.3685 % |
| HUTCHMED CHINA LTD | 1.4071 % |
| Hygeia Healthcare Holdings Co Ltd | 2.6263 % |
| INNOCARE PHARMA LTD | 1.5378 % |
| INNOVENT BIOLOGICS INC | 6.6352 % |
| JIANGSU HENGRUI MEDICINE CO LTD CLASS A | 9.0 % |
| LIVZON PHARMACEUTICAL GROU-A | 1.8403 % |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD | 1.2425 % |
| REMEGEN CO LTD-A | 0.9747 % |
| SHANGHAI JUNSHI BIOSCIENCE | 3.3246 % |
| SHANGHAI RAAS BLOOD PRODUC-A | 4.2678 % |
| SHENZHEN KANGTAI BIOLOGICA-A | 2.7076 % |
| SIMCERE PHARMACEUTICAL GROUP | 1.2343 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 6.3227 % |
| WALVAX BIOTECHNOLOGY CO-A | 8.4759 % |
| WUXI APPTEC CO LTD-A | 9.0 % |
| WUXI BIOLOGICS CAYMAN INC | 9.0 % |
| ZAI LAB LTD | 3.2742 % |
| ZHEJIANG WOLWO BIO-PHARMAC-A | 2.511 % |
Solactive China Biotech v2 Index:
In the ordinary rebalance, the following index composition will be implemented effective open 16.01.2023:
| AKESO INC | 2.8181 % |
| APELOA PHARMACEUTICAL CO-A | 1.9768 % |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD | 0.7253 % |
| BETTA PHARMACEUTICALS CO L-A | 2.4804 % |
| BGI GENOMICS CO LTD-A | 1.5952 % |
| CANSINO BIOLOGICS INC | 0.3852 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.1369 % |
| DAAN GENE CO LTD-A | 2.2629 % |
| GENSCRIPT BIOTECH CORP | 3.1302 % |
| HANSOH PHARMACEUTICAL GROUP CO | 2.2473 % |
| HUALAN BIOLOGICAL ENGINEER-A | 3.4914 % |
| HUBEI JUMPCAN PHARMACEUT-A | 1.3685 % |
| HUTCHMED CHINA LTD | 1.4071 % |
| Hygeia Healthcare Holdings Co Ltd | 2.6263 % |
| INNOCARE PHARMA LTD | 1.5378 % |
| INNOVENT BIOLOGICS INC | 6.6352 % |
| JIANGSU HENGRUI MEDICINE CO LTD CLASS A | 9.0 % |
| LIVZON PHARMACEUTICAL GROU-A | 1.8403 % |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD | 1.2425 % |
| REMEGEN CO LTD-A | 0.9747 % |
| SHANGHAI JUNSHI BIOSCIENCE | 3.3246 % |
| SHANGHAI RAAS BLOOD PRODUC-A | 4.2678 % |
| SHENZHEN KANGTAI BIOLOGICA-A | 2.7076 % |
| SIMCERE PHARMACEUTICAL GROUP | 1.2343 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 6.3227 % |
| WALVAX BIOTECHNOLOGY CO-A | 8.4759 % |
| WUXI APPTEC CO LTD-A | 9.0 % |
| WUXI BIOLOGICS CAYMAN INC | 9.0 % |
| ZAI LAB LTD | 3.2742 % |
| ZHEJIANG WOLWO BIO-PHARMAC-A | 2.511 % |